Does photodynamic therapy combined with ranibizumab achieve higher polyp regression than ranibizumab alone in polypoidal choroidal vasculopathy?

We analyzed the available evidence on photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy, and what we’ve found so far suggests that adding photodynamic therapy may lead to higher rates of polyp regression compared to ranibizumab alone. In patients who have not...